異種移植の世界市場レポート 2024年

異種移植の市場規模は、今後数年間で大幅な成長が見込まれています。 2028年には8.2%の年間複合成長率（CAGR）で199億6,000万米ドルに成長すると予想されます。予測期間中に予想される成長は、世界の医療インフラの進歩、公的資金の増加、遠隔医療の拡大、医療技術に対する国民の認識と受容の高まり、医療におけるAIの使用によって促進されます。この期間に予想される主要動向には、パーソナライズされた異種移植、多臓器移植手順の開発、精密医療アプローチとの統合の強化、患者向けの長期モニタリングソリューションの採用、セキュリティとデータ管理を強化するためのブロックチェーン技術の使用が含まれます。

組織と臓器移植の需要の急増は、異種移植市場の成長を促進すると予想されます。多発性嚢胞腎、嚢胞性線維症、心臓機能不全などの症状により、多くの人が臓器移植を必要とすることがよくあります。しかし、臓器移植の需要が高いため、移植に利用できる臓器が不足しています。 異種移植は、人間以外の臓器を人間の臓器の代替として利用することで、この不足に対処する解決策として登場しました。例えば、米国の臓器提供・移植システムにおける専門家の調整を促進するOrgan Procurement and Transplantation Network（OPTN）が2022年1月に発表した報告書によると、米国の臓器移植数は2020年の4万件から急増しました。 2021年には5.9%増加して4万1,354台に増加しました。したがって、組織と臓器移植の需要の高まりは、異種移植市場の成長の原動力となると予想されます。

外科手術の増加により、将来、異種移植市場の拡大が促進されると予想されます。これらの手順には、病状を診断または対処するための手動または機器による方法が含まれます。 異種移植は、ある種から別の種への臓器、組織、または細胞の移植を伴うもので、外科分野に革命をもたらす大きな可能性を秘めています。移植に利用できる人間の臓器が不足しているため、代替ソリューションとして異種移植が登場しました。たとえば、美容形成外科を専門とする主要組織であるAesthetic Societyの報告によると、2022年4月には、外科的処置は前年比54％増加し、非外科的処置は44％増加しました。したがって、外科手術の件数の増加が、異種移植市場の成長の背後にある重要な推進力となっています。

目次

第1章 エグゼクティブサマリー

第2章 市場の特徴

第3章 市場動向と戦略

第4章 マクロ経済シナリオ

• 高インフレが市場に与える影響
• ウクライナ・ロシア戦争が市場に与える影響
• COVID-19による市場への影響

第5章 世界市場規模と成長

• 世界の異種移植市場の促進要因と抑制要因
  • 市場促進要因
  • 市場抑制要因
• 世界の異種移植の市場規模実績と成長、2018～2023年
• 世界の異種移植市場規模と成長予測、2023～2028年、2033年

第6章 市場セグメンテーション

• 世界の異種移植市場、製品別セグメンテーション、実績と予測、2018～2023年、2023～2028年、2033年
• 臓器保存溶液
• 移植診断
• 組織製品
• 世界の異種移植市場、治療別セグメンテーション、実績と予測、2018～2023年、2023～2028年、2033年
• 鎮痛剤
• 免疫抑制剤
• その他
• 世界の異種移植市場、用途別セグメンテーション、実績と予測、2018～2023年、2023～2028年、2033年
• 心臓
• 腎臓
• その他
• 世界の異種移植市場、エンドユーザー別セグメンテーション、実績と予測、2018～2023年、2023～2028年、2033年
• 病院
• 移植センター
• その他

第7章 地域と国の分析

• 世界の異種移植市場、地域別、実績と予測、2018～2023年、2023～2028年、2033年
• 世界の異種移植市場、国別、実績と予測、2018～2023年、2023～2028年、2033年

第8章 アジア太平洋市場

第9章 中国市場

第10章 インド市場

第11章 日本市場

第12章 オーストラリア市場

第13章 インドネシア市場

第14章 韓国市場

第15章 西欧市場

第16章 英国市場

第17章 ドイツ市場

第18章 フランス市場

第19章 イタリア市場

第20章 スペイン市場

第21章 東欧市場

第22章 ロシア市場

第23章 北米市場

第24章 米国市場

第25章 カナダ市場

第26章 南米市場

第27章 ブラジル市場

第28章 中東市場

第29章 アフリカ市場

第30章 競合情勢と企業プロファイル

• 異種移植市場の競合情勢
• 異種移植市場の企業プロファイル
  • Novartis AG
  • Moderna Therapeutics
  • Astellas Pharma
  • United Therapeutics
  • Preservation Solutions

第31章 その他の主要と革新的な企業

• OrganOX Limited
• Innovent Biologics
• VivaBiome
• Talaris Therapeutics
• TransMedic Inc.
• Sirnaomics
• Sernova Corp
• Nova Lung
• Viela Bio
• Recombinetics
• Tissue Regenix
• TissueGene
• SAB Biotherapeutics
• eGenesis
• OrphoMed

第32章 競合ベンチマーキング

第33章 競合ダッシュボード

第34章 主要な合併と買収

第35章 将来の展望と潜在性分析

第36章 付録

Xenotransplantation involves transplanting nonhuman animal cells, tissues, or organs into humans, or vice versa, including ex vivo contact between human and nonhuman animal tissues.

The main products in the field of xenotransplantation include organ preservation solutions, transplant diagnostics, and tissue products. Organ preservation solutions are designed to reduce ischemic and hypoxic damage during cold storage, thereby enhancing graft survival. This category encompasses techniques such as machine perfusion, in situ core cooling, and various organ preservation fluids. Treatments related to xenotransplantation involve the use of analgesics, immunosuppressants, and other therapeutic approaches applicable to organs such as the heart and kidney. End-users of xenotransplantation products include hospitals, transplant centers, and other relevant institutions.

The xenotransplantation market research report is one of a series of new reports from The Business Research Company that provides xenotransplantation market statistics, including xenotransplantation industry global market size, regional shares, competitors with a xenotransplantation market share, detailed xenotransplantation market segments, market trends and opportunities, and any further data you may need to thrive in the xenotransplantation industry. This xenotransplantation market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The xenotransplantation market size has grown strongly in recent years. It will grow from $13.48 billion in 2023 to $14.58 billion in 2024 at a compound annual growth rate (CAGR) of 8.2%. The growth in the historic period can be attributed to the growing demand for organ transplants, animal breeding, clinical trials, as well as advancements in regulatory approvals and surgical techniques.

The xenotransplantation market size is expected to see strong growth in the next few years. It will grow to $19.96 billion in 2028 at a compound annual growth rate (CAGR) of 8.2%. The anticipated growth in the forecast period is driven by advancements in global healthcare infrastructure, increased public funding, the expansion of telemedicine, growing public perception and acceptance of medical technologies, and the use of AI in healthcare. Major trends expected in this period include personalized xenotransplantation, the development of multi-organ transplant procedures, greater integration with precision medicine approaches, the adoption of long-term monitoring solutions for patients, and the use of blockchain technology to enhance security and data management in healthcare.

The surge in demand for tissue and organ transplantation is anticipated to drive the growth of the xenotransplantation market. Conditions such as polycystic kidney disease, cystic fibrosis, or heart malfunctions often necessitate organ transplants for a significant number of individuals. However, the high demand for organ transplants has resulted in a shortage of available organs for transplantation. Xenotransplantation emerges as a solution to address this shortage by utilizing nonhuman organs as alternatives to human organs. For instance, as per a report published in January 2022 by the Organ Procurement and Transplantation Network (OPTN), which facilitates the coordination of professionals in the U.S. donation and transplantation system, the number of organ transplants in the United States surged from 40,000 in 2020 to 41,354 in 2021, reflecting a 5.9% increase. Consequently, the escalating demand for tissue and organ transplantation is expected to be the driving force behind the growth of the xenotransplantation market.

The rise in surgical procedures is anticipated to drive the expansion of the xenotransplantation market in the future. These procedures involve manual or instrumental methods to diagnose or address medical conditions. Xenotransplantation, which involves transplanting organs, tissues, or cells from one species to another, holds significant promise for revolutionizing the realm of surgery. Due to the scarcity of human organs available for transplantation, xenotransplantation has emerged as an alternative solution. For instance, in April 2022, as reported by The Aesthetic Society, a premier organization dedicated to aesthetic plastic surgery, surgical procedures surged by 54%, while non-surgical procedures increased by 44% compared to the previous year. Consequently, the increasing number of surgical procedures is a key driver behind the growth of the xenotransplantation market.

Major companies in the xenotransplantation market are introducing new technologies, such as preservation technology, to enhance the preservation methods and efficiency for delicate organs. Preservation technology encompasses various tools and methodologies used to protect and maintain the integrity of valuable objects, information, or environments over time. For example, in January 2022, XVIVO, a Sweden-based medical technology company focused on developing optimized solutions for organ, tissue, and cell preservation, introduced an innovative technique for efficiently storing and transporting donated hearts. The organ shortage is a significant challenge facing the transplant industry, limiting the number of patients with end-stage heart disease who receive transplant opportunities. This shortage leads to many patients passing away while awaiting a suitable organ. Xenotransplantation, which involves transplanting organs between different species, is one potential approach to address this severe scarcity. A recent groundbreaking study utilizing XVIVO's heart preservation technology achieved long-term survival following the xenotransplantation of gene-modified pig hearts into primates. This advancement holds promise for addressing the organ shortage crisis and improving transplant outcomes.

Major companies in the xenotransplantation market are prioritizing strategic partnerships to deliver reliable services to their customers. A strategic partnership is an arrangement between two or more companies or organizations that collaborate to achieve their respective goals. For example, in April 2023, Karius, a US-based company and a global leader in liquid biopsy for infectious diseases, formed a partnership with eGenesis, Inc., a US-based biotechnology company at the forefront of xenotransplantation research. The purpose of this collaboration is to develop human-compatible organs and cells for treating organ failure. By leveraging Karius's platform, which is capable of identifying and measuring diseases present in organ donors from pigs, the partnership aims to create a more comprehensive testing platform for microbial cell-free DNA. This platform will serve as the basis for surveillance and monitoring before and after transplantation, ultimately contributing to the alleviation of organ shortages and accelerating the availability of safe xenotransplantation.

In October 2023, United Therapeutics Corporation, a US-based biotechnology company, acquired Miromatrix Medical for $91 million. This strategic acquisition is intended to expand United Therapeutics' existing organ production initiatives, which include xenotransplantation, 3-D bioprinting, x-vivo lung perfusion, and regenerative medicine techniques. Miromatrix Medical, based in the US, is a development-stage company known for its fully implantable manufactured kidney product.

Major companies operating in the xenotransplantation market report are Novartis AG, Moderna Therapeutics, Astellas Pharma, United Therapeutics, Preservation Solutions, OrganOX Limited, Innovent Biologics, VivaBiome, Talaris Therapeutics, TransMedic Inc., Sirnaomics, Sernova Corp, Nova Lung, Viela Bio, Recombinetics, Tissue Regenix, TissueGene, SAB Biotherapeutics, eGenesis, OrphoMed, Revivicor, Veloxis Pharmaceuticals, Geneo, Organ Recovery Systems, CRISPR Therapeutics, Qihan Biotech, Sino-Clone Organ Biotechnology, Xenothera, Intrexon Corporation, Lung Biotechnology, Cabaletta Bio, Arcturus Therapeutics, CSL Behring, Pfizer Inc., Bayer AG, AbbVie Inc.

North America was the largest region in the xenotransplantation market in 2023. The regions covered in the xenotransplantation market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the xenotransplantation market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The xenotransplantation market includes revenues earned by entities by providing transplantation and diagnostics. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Xenotransplantation Global Market Report 2024 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on xenotransplantation market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 50+ geographies.
• Understand how the market has been affected by the coronavirus and how it is responding as the impact of the virus abates.
• Assess the Russia - Ukraine war's impact on agriculture, energy and mineral commodity supply and its direct and indirect impact on the market.
• Measure the impact of high global inflation on market growth.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on the latest market shares.
• Benchmark performance against key competitors.
• Suitable for supporting your internal and external presentations with reliable high quality data and analysis
• Report will be updated with the latest data and delivered to you within 3-5 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for xenotransplantation ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The xenotransplantation market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

• The market characteristics section of the report defines and explains the market.
• The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
• The forecasts are made after considering the major factors currently impacting the market. These include:

The impact of sanctions, supply chain disruptions, and altered demand for goods and services due to the Russian Ukraine war, impacting various macro-economic factors and parameters in the Eastern European region and its subsequent effect on global markets.

The impact of higher inflation in many countries and the resulting spike in interest rates.

The continued but declining impact of covid 19 on supply chains and consumption patterns.

• Market segmentations break down the market into sub markets.
• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
• The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

Markets Covered:

• 1) By Products: Organ Preservation Solutions; Transplant Diagnostics; Tissue Products
• 2) By Treatment: Analgesic; Immunosuppressant; Other Treatments
• 3) By Applications: Heart; Kidney; Other Organs
• 4) By End-Users: Hospitals; Transplant Centers; Other End-Users
• Companies Mentioned: Novartis AG; Moderna Therapeutics; Astellas Pharma; United Therapeutics; Preservation Solutions
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
• Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Xenotransplantation Market Characteristics

3. Xenotransplantation Market Trends And Strategies

4. Xenotransplantation Market - Macro Economic Scenario

• 4.1. Impact Of High Inflation On The Market
• 4.2. Ukraine-Russia War Impact On The Market
• 4.3. COVID-19 Impact On The Market

5. Global Xenotransplantation Market Size and Growth

• 5.1. Global Xenotransplantation Market Drivers and Restraints
  • 5.1.1. Drivers Of The Market
  • 5.1.2. Restraints Of The Market
• 5.2. Global Xenotransplantation Historic Market Size and Growth, 2018 - 2023, Value ($ Billion)
• 5.3. Global Xenotransplantation Forecast Market Size and Growth, 2023 - 2028, 2033F, Value ($ Billion)

6. Xenotransplantation Market Segmentation

• 6.1. Global Xenotransplantation Market, Segmentation By Products, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• Organ Preservation Solutions
• Transplant Diagnostics
• Tissue Products
• 6.2. Global Xenotransplantation Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• Analgesic
• Immunosuppressant
• Other Treatments
• 6.3. Global Xenotransplantation Market, Segmentation By Applications, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• Heart
• Kidney
• Other Organs
• 6.4. Global Xenotransplantation Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• Hospitals
• Transplant Centers
• Other End-Users

7. Xenotransplantation Market Regional And Country Analysis

• 7.1. Global Xenotransplantation Market, Split By Region, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 7.2. Global Xenotransplantation Market, Split By Country, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

8. Asia-Pacific Xenotransplantation Market

• 8.1. Asia-Pacific Xenotransplantation Market Overview
• Region Information, Impact Of COVID-19, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 8.2. Asia-Pacific Xenotransplantation Market, Segmentation By Products, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 8.3. Asia-Pacific Xenotransplantation Market, Segmentation By Applications, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 8.4. Asia-Pacific Xenotransplantation Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

9. China Xenotransplantation Market

• 9.1. China Xenotransplantation Market Overview
• 9.2. China Xenotransplantation Market, Segmentation By Products, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
• 9.3. China Xenotransplantation Market, Segmentation By Applications, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
• 9.4. China Xenotransplantation Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion

10. India Xenotransplantation Market

• 10.1. India Xenotransplantation Market, Segmentation By Products, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 10.2. India Xenotransplantation Market, Segmentation By Applications, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 10.3. India Xenotransplantation Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

11. Japan Xenotransplantation Market

• 11.1. Japan Xenotransplantation Market Overview
• 11.2. Japan Xenotransplantation Market, Segmentation By Products, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 11.3. Japan Xenotransplantation Market, Segmentation By Applications, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 11.4. Japan Xenotransplantation Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

12. Australia Xenotransplantation Market

• 12.1. Australia Xenotransplantation Market, Segmentation By Products, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 12.2. Australia Xenotransplantation Market, Segmentation By Applications, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 12.3. Australia Xenotransplantation Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

13. Indonesia Xenotransplantation Market

• 13.1. Indonesia Xenotransplantation Market, Segmentation By Products, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 13.2. Indonesia Xenotransplantation Market, Segmentation By Applications, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 13.3. Indonesia Xenotransplantation Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

14. South Korea Xenotransplantation Market

• 14.1. South Korea Xenotransplantation Market Overview
• 14.2. South Korea Xenotransplantation Market, Segmentation By Products, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 14.3. South Korea Xenotransplantation Market, Segmentation By Applications, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 14.4. South Korea Xenotransplantation Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

15. Western Europe Xenotransplantation Market

• 15.1. Western Europe Xenotransplantation Market Overview
• 15.2. Western Europe Xenotransplantation Market, Segmentation By Products, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 15.3. Western Europe Xenotransplantation Market, Segmentation By Applications, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 15.4. Western Europe Xenotransplantation Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

16. UK Xenotransplantation Market

• 16.1. UK Xenotransplantation Market, Segmentation By Products, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 16.2. UK Xenotransplantation Market, Segmentation By Applications, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 16.3. UK Xenotransplantation Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

17. Germany Xenotransplantation Market

• 17.1. Germany Xenotransplantation Market, Segmentation By Products, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 17.2. Germany Xenotransplantation Market, Segmentation By Applications, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 17.3. Germany Xenotransplantation Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

18. France Xenotransplantation Market

• 18.1. France Xenotransplantation Market, Segmentation By Products, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 18.2. France Xenotransplantation Market, Segmentation By Applications, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 18.3. France Xenotransplantation Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

19. Italy Xenotransplantation Market

• 19.1. Italy Xenotransplantation Market, Segmentation By Products, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 19.2. Italy Xenotransplantation Market, Segmentation By Applications, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 19.3. Italy Xenotransplantation Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

20. Spain Xenotransplantation Market

• 20.1. Spain Xenotransplantation Market, Segmentation By Products, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 20.2. Spain Xenotransplantation Market, Segmentation By Applications, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 20.3. Spain Xenotransplantation Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

21. Eastern Europe Xenotransplantation Market

• 21.1. Eastern Europe Xenotransplantation Market Overview
• 21.2. Eastern Europe Xenotransplantation Market, Segmentation By Products, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 21.3. Eastern Europe Xenotransplantation Market, Segmentation By Applications, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 21.4. Eastern Europe Xenotransplantation Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

22. Russia Xenotransplantation Market

• 22.1. Russia Xenotransplantation Market, Segmentation By Products, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 22.2. Russia Xenotransplantation Market, Segmentation By Applications, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 22.3. Russia Xenotransplantation Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

23. North America Xenotransplantation Market

• 23.1. North America Xenotransplantation Market Overview
• 23.2. North America Xenotransplantation Market, Segmentation By Products, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 23.3. North America Xenotransplantation Market, Segmentation By Applications, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 23.4. North America Xenotransplantation Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

24. USA Xenotransplantation Market

• 24.1. USA Xenotransplantation Market Overview
• 24.2. USA Xenotransplantation Market, Segmentation By Products, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 24.3. USA Xenotransplantation Market, Segmentation By Applications, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 24.4. USA Xenotransplantation Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

25. Canada Xenotransplantation Market

• 25.1. Canada Xenotransplantation Market Overview
• 25.2. Canada Xenotransplantation Market, Segmentation By Products, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 25.3. Canada Xenotransplantation Market, Segmentation By Applications, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 25.4. Canada Xenotransplantation Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

26. South America Xenotransplantation Market

• 26.1. South America Xenotransplantation Market Overview
• 26.2. South America Xenotransplantation Market, Segmentation By Products, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 26.3. South America Xenotransplantation Market, Segmentation By Applications, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 26.4. South America Xenotransplantation Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

27. Brazil Xenotransplantation Market

• 27.1. Brazil Xenotransplantation Market, Segmentation By Products, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 27.2. Brazil Xenotransplantation Market, Segmentation By Applications, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 27.3. Brazil Xenotransplantation Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

28. Middle East Xenotransplantation Market

• 28.1. Middle East Xenotransplantation Market Overview
• 28.2. Middle East Xenotransplantation Market, Segmentation By Products, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 28.3. Middle East Xenotransplantation Market, Segmentation By Applications, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 28.4. Middle East Xenotransplantation Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

29. Africa Xenotransplantation Market

• 29.1. Africa Xenotransplantation Market Overview
• 29.2. Africa Xenotransplantation Market, Segmentation By Products, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 29.3. Africa Xenotransplantation Market, Segmentation By Applications, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 29.4. Africa Xenotransplantation Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

30. Xenotransplantation Market Competitive Landscape And Company Profiles

• 30.1. Xenotransplantation Market Competitive Landscape
• 30.2. Xenotransplantation Market Company Profiles
  • 30.2.1. Novartis AG
    • 30.2.1.1. Overview
    • 30.2.1.2. Products and Services
    • 30.2.1.3. Strategy
    • 30.2.1.4. Financial Performance
  • 30.2.2. Moderna Therapeutics
    • 30.2.2.1. Overview
    • 30.2.2.2. Products and Services
    • 30.2.2.3. Strategy
    • 30.2.2.4. Financial Performance
  • 30.2.3. Astellas Pharma
    • 30.2.3.1. Overview
    • 30.2.3.2. Products and Services
    • 30.2.3.3. Strategy
    • 30.2.3.4. Financial Performance
  • 30.2.4. United Therapeutics
    • 30.2.4.1. Overview
    • 30.2.4.2. Products and Services
    • 30.2.4.3. Strategy
    • 30.2.4.4. Financial Performance
  • 30.2.5. Preservation Solutions
    • 30.2.5.1. Overview
    • 30.2.5.2. Products and Services
    • 30.2.5.3. Strategy
    • 30.2.5.4. Financial Performance

31. Xenotransplantation Market Other Major And Innovative Companies

• 31.1. OrganOX Limited
• 31.2. Innovent Biologics
• 31.3. VivaBiome
• 31.4. Talaris Therapeutics
• 31.5. TransMedic Inc.
• 31.6. Sirnaomics
• 31.7. Sernova Corp
• 31.8. Nova Lung
• 31.9. Viela Bio
• 31.10. Recombinetics
• 31.11. Tissue Regenix
• 31.12. TissueGene
• 31.13. SAB Biotherapeutics
• 31.14. eGenesis
• 31.15. OrphoMed

32. Global Xenotransplantation Market Competitive Benchmarking

33. Global Xenotransplantation Market Competitive Dashboard

34. Key Mergers And Acquisitions In The Xenotransplantation Market

35. Xenotransplantation Market Future Outlook and Potential Analysis

• 35.1 Xenotransplantation Market In 2028 - Countries Offering Most New Opportunities
• 35.2 Xenotransplantation Market In 2028 - Segments Offering Most New Opportunities
• 35.3 Xenotransplantation Market In 2028 - Growth Strategies
  • 35.3.1 Market Trend Based Strategies
  • 35.3.2 Competitor Strategies

36. Appendix

• 36.1. Abbreviations
• 36.2. Currencies
• 36.3. Historic And Forecast Inflation Rates
• 36.4. Research Inquiries
• 36.5. The Business Research Company
• 36.6. Copyright And Disclaimer